Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer, MK Callahan… - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
[PDF][PDF] PrIMEr
M Ramos-Casals, JR Brahmer, MK Callahan… - enterobiotix.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Immune-related adverse events of checkpoint inhibitors.
M Ramos-Casals, JR Brahmer… - Nature reviews …, 2020 - europepmc.org
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors (ICIs), which target PD-1, PD-L1 …
few decades. Among them, immune checkpoint inhibitors (ICIs), which target PD-1, PD-L1 …
Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer… - Nature Reviews …, 2020 - mdanderson.elsevierpure.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer… - Nature reviews …, 2020 - pubmed.ncbi.nlm.nih.gov
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
[引用][C] Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer, MK Callahan… - Nature Reviews …, 2020 - cir.nii.ac.jp
Immune-related adverse events of checkpoint inhibitors | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[HTML][HTML] Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer… - Nature reviews …, 2020 - ncbi.nlm.nih.gov
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors (ICIs), which target PD-1, PD-L1 …
few decades. Among them, immune checkpoint inhibitors (ICIs), which target PD-1, PD-L1 …
Immune-related adverse events of checkpoint inhibitors (Primer)
M Ramos-Casals, JR Brahmer… - Nature Reviews …, 2020 - search.proquest.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer… - Nature Reviews …, 2020 - pure.johnshopkins.edu
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Immune-related adverse events of checkpoint inhibitors (Primer)
M Ramos-Casals, JR Brahmer… - Nature Reviews …, 2020 - search.proquest.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …